News/MT Newswires/Radius Health, Menarini Group Says Phase 3 Trial of Breast Cancer…Radius Health, Menarini Group Says Phase 3 Trial of Breast Cancer Drug Candidate Elacestrant Meets Primary EndpointMay 20, 202209:05 UTC